Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3245]

Molecule holds promise to reprogram white blood cells for better cancer treatment

Molecule holds promise to reprogram white blood cells for better cancer treatment

Scientists recruit new atomic heavyweights in targeted fight against cancer

Scientists recruit new atomic heavyweights in targeted fight against cancer

Study finds paediatric cancer patients at no greater risk of severe COVID-19 infection

Study finds paediatric cancer patients at no greater risk of severe COVID-19 infection

ASH 2020: CAR T cell therapy effective as first-line treatment for high-risk large B-cell lymphoma

ASH 2020: CAR T cell therapy effective as first-line treatment for high-risk large B-cell lymphoma

ASH 2020: New treatment uncovered for AL amyloidosis

ASH 2020: New treatment uncovered for AL amyloidosis

ASH 2020: Chemotherapy and blinatumomab improves survival for patients with B-cell acute lymphoblastic leukaemia

ASH 2020: Chemotherapy and blinatumomab improves survival for patients with B-cell acute lymphoblastic leukaemia

ASH 2020: CRISPR-edited CAR T cells enhance fight against blood cancers

ASH 2020: CRISPR-edited CAR T cells enhance fight against blood cancers

ASH 2020: Early phase studies show promise in acute myeloid leukaemia

ASH 2020: Early phase studies show promise in acute myeloid leukaemia

ASH 2020: Follow up data on venetoclax in combination with rituximab or obinutuzumab for CLL shows continued survival benefit

ASH 2020: Follow up data on venetoclax in combination with rituximab or obinutuzumab for CLL shows continued...

ASH 2020: Off-the-shelf immune drug shows promise in aggressive multiple myeloma

ASH 2020: Off-the-shelf immune drug shows promise in aggressive multiple myeloma

More from ecancer